Related Experiment Video
Updated: May 25, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Therapeutics in Huntington's Disease
Annie Killoran1, Kevin M Biglan
1Experimental Therapeutics in Movement Disorders, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 223, Rochester, NY, 14620, USA, Annie_Killoran@URMC.Rochester.edu.
Insights
Huntington's disease (HD) management focuses on symptom relief and support, as no cure exists. Treatment strategies prioritize managing motor, psychiatric, and cognitive symptoms, often using a multidisciplinary approach.
Area of Science:
- Neurology
- Genetics
- Psychiatry
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder with no specific cure.
- Management of HD involves addressing motor, psychiatric, and cognitive symptoms through symptomatic relief, rehabilitation, and support.
- Current pharmacotherapy for HD is limited, with tetrabenazine (an antichoreic agent) used cautiously due to risks of depression and suicidality.
Purpose of the Study:
- To review current management strategies for Huntington's disease (HD).
- To highlight the challenges in treating HD symptoms, particularly cognitive impairment.
- To emphasize the importance of a multidisciplinary approach in managing HD.
Main Methods:
- This is an opinion statement based on current clinical practice and literature review.
- Discussion of pharmacologic and non-pharmacologic interventions for HD symptoms.
- Emphasis on the role of a multidisciplinary team in HD care.
Main Results:
- There is no specific treatment for Huntington's disease (HD).
- Symptomatic management includes addressing motor (chorea), psychiatric (depression, agitation), and cognitive decline.
- Neuroleptics are often first-line for chorea with psychiatric comorbidities; antidepressants, mood stabilizers, anxiolytics, and psychostimulants are also used.
- Cognitive impairment in HD remains a significant unmet therapeutic need.
- Multipurpose medications can simplify regimens and improve compliance.
- A multidisciplinary team approach is crucial for comprehensive HD management.
Conclusions:
- Effective Huntington's disease (HD) management requires a comprehensive, multidisciplinary approach.
- Addressing psychiatric symptoms is often a primary focus due to their significant impact.
- Further research is needed to develop effective treatments for cognitive impairment in HD.
Abstract:
OPINION STATEMENT: There is no specific treatment for Huntington's disease (HD). Its many symptoms of motor, psychiatric, and cognitive deterioration are managed with symptomatic relief, rehabilitation, and support. The only drug approved by the US Food and Drug Administration (FDA) for the treatment of HD is an antichoreic agent, tetrabenazine, but this drug is used sparingly because of uneasiness regarding its propensity to cause depression and suicidality in this population, which is already at risk for these complications. Neuroleptics are still first-line treatments for chorea accompanied by comorbid depression and/or behavioral or psychotic symptoms, as is often the case. Psychiatric features, which have a significant impact on a patient's professional and personal life, often become the major focus of management. In addition to neuroleptics, commonly used medications include antidepressants, mood stabilizers, anxiolytics, and psychostimulants. In contrast, few treatment options are available for cognitive impairment in HD; this remains an important and largely unmet therapeutic need. HD patients typically lack insight into their disease manifestations, failing to recognize their need for treatment, and possibly even arguing against it. Multipurpose medications are employed advantageously to simplify the medication regimen, so as to facilitate compliance and not overwhelm the patient. For example, haloperidol can be prescribed for a patient with chorea, agitation, and anorexia, rather than targeting each symptom with a different drug. This approach also limits the potential for adverse effects, which can be difficult to distinguish from the features of the disease itself. With HD's complexity, it is best managed with a multidisciplinary approach that includes a movement disorders specialist, a genetic counselor, a mental health professional, a physical therapist, and a social worker for support and coordination of services. As the disease progresses, there may be need for other specialists, such as a speech and occupational therapist, a nutritionist for weight loss, and ultimately, a palliative care specialist.
Related Concept Videos
Huntington Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment
Drug Therapy
Antianxiety Medications
Parkinson's Disease: Overview
Therapeutic Drug Monitoring: Overview and Classification

